Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "Drug-discovery"

303 News Found

IHub-Data and IIIT-Hyderabad offer course on drug discovery
News | March 03, 2022

IHub-Data and IIIT-Hyderabad offer course on drug discovery

12-week certificate course commences on March 10th 2022


PrecisionLife appoints Colin Stubberfield as SVP Drug Discovery
People | February 22, 2022

PrecisionLife appoints Colin Stubberfield as SVP Drug Discovery

He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,


Alloy Therapeutics acquires deepCDR Biologics to bring ML into drug discovery
Digitisation | December 17, 2021

Alloy Therapeutics acquires deepCDR Biologics to bring ML into drug discovery

The deepCDR engine combines deep sequencing and deep learning methods with a proprietary mammalian display process to select from a wide range of antibodies and rapidly identify candidates with the highest possible affinity and developability profiles


Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics
Biotech | August 10, 2021

Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics

Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments


Global clinical trials are shifting east. Is India ready to lead?
Clinical Trials | June 27, 2026

Global clinical trials are shifting east. Is India ready to lead?

At the latest Indian Pharma Post E-Conference, leading experts identified faster regulatory approvals, infrastructure, digital innovation, investigator training, and public trust as critical pillars


Merck KGaA to acquire Bio-Techne for $11.3 Billion in major life sciences deal
Biopharma | June 26, 2026

Merck KGaA to acquire Bio-Techne for $11.3 Billion in major life sciences deal

Acquisition strengthens Merck's life sciences portfolio, expands capabilities across research and biopharma manufacturing


AI moves from experimentation to enterprise tool across pharma value chain: GlobalData
Digitisation | June 25, 2026

AI moves from experimentation to enterprise tool across pharma value chain: GlobalData

34% of pharma firms have already deployed function-specific AI, with drug discovery, clinical trials, and medical writing emerging as key high-impact use cases


Apexon partners with AWS to accelerate Agentic AI adoption in healthcare and life-sciences
Digitisation | June 24, 2026

Apexon partners with AWS to accelerate Agentic AI adoption in healthcare and life-sciences

Partnership combines Apexon's agentic AI platforms and cloud modernization tools with AWS infrastructure to accelerate AI deployment, clinical innovation, and digital transformation across healthcare and life sciences


LabGenius and LG Chem strike AI-powered deal to develop next-gen tumour-targeting antibody therapy
News | June 21, 2026

LabGenius and LG Chem strike AI-powered deal to develop next-gen tumour-targeting antibody therapy

The collaboration is focused on overcoming a major limitation in existing cancer drugs


Alithea Genomics and Revvity expand global access to scalable transcriptomics platforms
R&D | June 16, 2026

Alithea Genomics and Revvity expand global access to scalable transcriptomics platforms

Collaboration integrates MERCURIUS DRUG-seq technologies with Revvity’s screening portfolio, enabling scalable transcriptomic profiling for next-generation drug discovery and AI-driven research